Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537283 | Vaccine | 2017 | 8 Pages |
Abstract
Strong Tfh activation in response to influenza vaccination forecasts successful seroconversion in older adults, and HD IIV elicits greater Tfh activation than SD IIV. Future vaccine studies should focus on ways to further optimize the Tfh response.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Mark A. Pilkinton, Katherine J. Nicholas, Christian M. Warren, Rita M. Smith, Sandra M. Yoder, H. Keipp Talbot, Spyros A. Kalams,